Citicoline (also called CDP-choline or cytidine-5-diphosphocholine) is the endogenous compound that is one of the most potent and most widely studied neuroprotective agents — it is a key intermediate in the phosphatidylcholine synthesis pathway, and it is used in the brain as the substrate for the synthesis of the acetylcholine, the phosphatidylcholine, and the other phospholipids that are essential for the neuronal membrane integrity and for the synaptic function. The citicoline is unique among the nootropics because it has multiple and complementary mechanisms of action — it provides the choline for the acetylcholine synthesis (thereby supporting the memory and the cognitive function), it provides the cytidine and the choline for the phosphatidylcholine synthesis (thereby supporting the neuronal membrane repair and the myelin sheath maintenance), it increases the norepinephrine and the dopamine levels in the brain (thereby improving the attention and the mood), and it reduces the phospholipase A2 activity (thereby preventing the neuronal membrane degradation and the excitotoxicity). Without adequate citicoline and neuronal membrane support, the membrane repair is impaired, the acetylcholine synthesis is reduced, and the cognitive decline accelerates — the hallmark of the citicoline deficiency and of the impaired phospholipid metabolism that is associated with the stroke, the traumatic brain injury, and the neurodegenerative diseases. The typical citicoline supplement dose is 500-2000mg daily — making it one of the most evidence-based and most widely used neuroprotective agents for the cognitive support, for the stroke recovery, and for the neurodegenerative disease management.
Citicoline and the Neuronal Membrane Repair
Citicoline supports the neuronal membrane repair primarily through its role as a key intermediate in the phosphatidylcholine synthesis pathway — the citicoline is converted to the phosphatidylcholine through the CDP-choline pathway, which is the primary pathway for the phosphatidylcholine synthesis in the mammalian cells. The phosphatidylcholine is the most abundant phospholipid in the neuronal membranes (constituting approximately 40-50% of the total phospholipids in the neuronal plasma membrane), and it is essential for the membrane integrity, the membrane fluidity, the receptor function, and the synaptic transmission. During the brain injury (stroke, traumatic brain injury, neurodegenerative disease), the neuronal membranes are damaged by the excitotoxicity, the oxidative stress, and the inflammation — and the phosphatidylcholine is degraded by the phospholipase A2 and by the other hydrolytic enzymes that are activated by the injury. The citicoline supplementation provides the substrate for the phosphatidylcholine synthesis and thereby supports the repair and the replacement of the damaged membrane phospholipids — which is one of the primary mechanisms of the citicoline’s neuroprotective effect. The citicoline also provides the choline for the acetylcholine synthesis — and this is particularly important in the ageing brain and in the Alzheimer’s disease, where the cholinergic hypofunction is one of the primary causes of the memory impairment and the cognitive decline.
The clinical importance of the citicoline for the stroke recovery is underscored by the observation that the citicoline supplementation improves the functional recovery and reduces the mortality in people with the acute ischemic stroke. A meta-analysis of 10 RCTs in over 4000 patients with the acute ischemic stroke found that the citicoline supplementation at 500-2000mg daily significantly improved the functional recovery (by 15-20%, as measured by the modified Rankin Scale and the Barthel Index) and reduced the mortality (by 10-15%) — making citicoline one of the most effective neuroprotective agents for the stroke recovery. The citicoline has also been shown to improve the cognitive function in people with the chronic cerebrovascular disease, in people with the mild cognitive impairment, and in the healthy older adults — making it one of the most versatile and most evidence-based neuroprotective agents available.
Practical Application
For general citicoline supplementation for the neuroprotective support, the evidence-based approach is to supplement with 500-2000mg of citicoline daily (as the pure CDP-choline powder or capsule, taken 1-2 times per day with the meals). The citicoline should be taken in the morning and in the early afternoon (to avoid the insomnia that can be caused by the increased norepinephrine and dopamine levels in the evening). The citicoline is generally well-tolerated with no significant adverse effects at doses up to 4000mg daily, and it does not have any significant drug interactions — though it may enhance the effects of the nootropic and the psychostimulant drugs. For comprehensive neuroprotective and cognitive support, citicoline pairs well with the acetyl-L-carnitine (which supports the mitochondrial function and which works synergistically with the citicoline for the neuronal energy metabolism and the neuroprotection), with the phosphatidylserine (which supports the neuronal membrane integrity and which works synergistically with the citicoline for the membrane repair and the cognitive function), with the alpha-GPC (which provides the choline precursor for the acetylcholine synthesis and which works synergistically with the citicoline for the cholinergic enhancement), and with the Ginkgo biloba (which enhances the cerebral blood flow and which works synergistically with the citicoline for the cerebral perfusion and the neuroprotection).
Leave a Reply